929881-05-0 Usage
Purpose
Gene therapy medication
Indication
Treatment of lipoprotein lipase deficiency (LPLD)
Condition
LPLD prevents the breakdown of fat molecules, leading to severe pancreatitis and other complications.
Mechanism of Action
Delivers a functional lipoprotein lipase gene to muscle cells to produce the necessary enzyme for fat breakdown.
Administration
One-time injection directly into the muscle
Efficacy
Promising results in improving symptoms and reducing pancreatitis risk in LPLD patients.
Regulatory Approval
First gene therapy approved in Europe in 2012.
Significance
Represents a major advancement in treating rare genetic diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 929881-05-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,9,8,8 and 1 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 929881-05:
(8*9)+(7*2)+(6*9)+(5*8)+(4*8)+(3*1)+(2*0)+(1*5)=220
220 % 10 = 0
So 929881-05-0 is a valid CAS Registry Number.